{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:12:50Z","timestamp":1773249170628,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T00:00:00Z","timestamp":1242345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12032-009-9231-y","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T11:24:05Z","timestamp":1242300245000},"page":"446-448","source":"Crossref","is-referenced-by-count":1,"title":["Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Thomas","family":"Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Medioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Augereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Oudard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"issue":"Suppl 1","key":"9231_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.5-suppl_1-45","volume":"5","author":"HM Verheul","year":"2000","unstructured":"Verheul HM, Hoekman K, Jorna AS, Smit EF, Pinedo HM. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation. Oncologist. 2000;5(Suppl 1):45\u201350. doi: 10.1634\/theoncologist.5-suppl_1-45 .","journal-title":"Oncologist"},{"key":"9231_CR2","first-page":"3364","volume":"5","author":"BK Zebrowski","year":"1999","unstructured":"Zebrowski BK, Yano S, Liu W, et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res. 1999;5:3364\u20138.","journal-title":"Clin Cancer Res"},{"key":"9231_CR3","first-page":"2594","volume":"58","author":"JC Luo","year":"1998","unstructured":"Luo JC, Toyoda M, Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor\/permeability factor neutralizing antibody. Cancer Res. 1998;58:2594\u2013600.","journal-title":"Cancer Res"},{"key":"9231_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-5-32","volume":"5","author":"SE Deprimo","year":"2007","unstructured":"Deprimo SE, Bello CL, Smeraglia J, et al. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl Med. 2007;5:32. doi: 10.1186\/1479-5876-5-32 .","journal-title":"J Transl Med"},{"key":"9231_CR5","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/art.20429","volume":"50","author":"M Demasi","year":"2004","unstructured":"Demasi M, Cleland LG, Cook-Johnson RJ, James MJ. Effects of hypoxia on the expression and activity of cyclooxygenase 2 in fibroblast-like synoviocytes: interactions with monocyte-derived soluble mediators. Arthritis Rheum. 2004;50:2441\u20139. doi: 10.1002\/art.20429 .","journal-title":"Arthritis Rheum"},{"key":"9231_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"9231_CR7","unstructured":"Salzman KL, Lillegard WA, Butcher JD. Upper extremity bursitis. Am Fam Physician. 1997;56:1797\u2013806, 1811\u20132."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9231-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9231-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9231-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:38Z","timestamp":1559427758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9231-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,15]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9231"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9231-y","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,15]]}}}